Diabetes Mellitus, Type 2 Clinical Trial
— DiminiOfficial title:
DIMINI - Activating of Health Literacy in Persons With an Increased Risk of Type 2 Diabetes Mellitus by Coaching at General Practitioners
The increasing prevalence of type 2 diabetes mellitus is a worldwide problem. In preventing risk factors and unhealthy lifestyle through improved health literacy, chances are seen to delay or even avoid type 2 diabetes mellitus. The aim of the DIMINI-project is to prevent type 2 diabetes mellitus and to strengthen the health literacy of people at increased risk of developing it. For this purpose, people at increased risk are first identified by using the standardized screening tool Finnish Diabetes Risk Score (FINDRISC) adapted for Germany. Identified risk persons then receive a needs-based, modular lifestyle intervention including nutrition tips and physical exercises either paper- or app-based.
Status | Recruiting |
Enrollment | 530 |
Est. completion date | July 1, 2020 |
Est. primary completion date | March 31, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - age = 18 years - resident in Hesse or Schleswig-Holstein - statutory health insurance in one out of five participating health insurances - overweight/obesity - low physical activity - known family disposition for type 2 diabetes mellitus - history of increased glucose levels - FINDRISC results with scores = 12 Exclusion Criteria: - age < 18 years - resident outside Hesse or Schleswig-Holstein - statutory or private health insurance with other than the participating health insurances - clinically manifested diabetes mellitus - malnutrition - psychiatric disorders - pregnancy - FINDRISC results with scores <12 - participation in other clinical trials |
Country | Name | City | State |
---|---|---|---|
Germany | docevent GmbH | Schleswig | Schleswig-Holstein |
Lead Sponsor | Collaborator |
---|---|
Dimini Konsortium | Deutsche Diabetes Gesellschaft |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body weight reduction | Survey of weight general practitioners level | 15 Months | |
Secondary | Health literacy (European Health Literacy Survey Questionnaire) | Summed scale: Maximum: 16 (best health literacy) Minimum: 0 (worst health literacy) = 13 = sufficient health literacy 9-12 = problematic health literacy = 8 = inadequate health literacy Higher values represent a better outcome |
15 Months | |
Secondary | Eating behaviour (German questionnaire on eating behaviour) | Three summed subscales: Scale 1) cognitive control of eating behavior, restrained eating Minimum score: 0 = no cognitive control Maximum score: 21 = extreme cognitive control Scale 2) disturbance of eating behavior Minimum score: 0 = no disturbance Maximum score: 16 = extreme disturbance Scale 3) experienced feelings of hunger Minimum score: 0 = no disturbing sensations of hunger Maximum score: 14 = very strong disturbing sensations of hunger For each item it is determined individually, which response option is considered to get a value of 1 or a value of 0 (e.g. Scale 1 Item 12: "true" = 1, "not true" = 0, Item 18 "true" = 0, "not true" = 1) |
15 Months | |
Secondary | Physical activity (International Physical Activity Questionnaire) | Questionnaire designed for population surveillance of physical activity among adults including Total Score: Maximum Score: 960 minutes Minimum Score: 10 minutes Categorical Score: Category 1 - Low: • Individuals who not meet criteria for Categories 2 or 3 Category 2 - Moderate: 3 or more days of vigorous-intensity activity of at least 20 minutes per day 5 or more days of moderate-intensity activity and/or walking of at least 30 minutes per day 5 or more days of any combination of walking, moderate-intensity or vigorous intensity activities achieving a minimum total physical activity of at least 600 minutes/week. Category 3 High vigorous-intensity activity on at least 3 days achieving a minimum total physical activity of at least 1500 minutes/week 7 or more days of any combination of walking, moderate-intensity or vigorous-intensity activities achieving a minimum total physical activity of at least 3000 minutes/week. |
15 Months | |
Secondary | Quality of life | Short Form 12 | 15 Months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |